Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
636-649
Author(s):
Silvia Martina Ferrari, Gabriele Materazzi, Enke Baldini, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli and Poupak Fallahi
Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
15
Page:
292-300
Author(s):
Juan C. Jurado-Coronel, Marco Ávila-Rodriguez, Valentina Echeverria, Oscar Alejandro Hidalgo, Janneth Gonzalez, Gjumrakch Aliev and George E. Barreto
Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
Journal:
Current Drug Metabolism
Volume:
17
Page:
308-316
Author(s):
Doriana Fruci, William C.S. Cho, Paolo Romania, Valerio Nobili, Franco Locatelli and Anna Alisi
Stem Cell Therapies
Journal:
Recent Patents on Regenerative Medicine
Volume:
5
Page:
145-151
Author(s):
Ana L. Muñoz, Víctor M. Galvez and María V. Camarasa
Albumin-Based Nanodevices as Drug Carriers
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
1371-1390
Author(s):
Ana Loureiro, Nuno G. Azoia, Andreia C. Gomes and Artur Cavaco-Paulo
The Pleiotropic Effects of PPARs on Vascular Cells and Angiogenesis: Implications for Tissue Engineering
Journal:
Current Stem Cell Research & Therapy
Volume:
11
Page:
265-273
Author(s):
Ke Sun, Renhuan Huang, Songtao Wu, Zhaozhao Chen, Shuwen Deng, Jinglin Zhou and Jing Xie
Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications
Journal:
Current Drug Targets
Volume:
17
Page:
508-514
Author(s):
Mikko O. Laukkanen and Maria Domenica Castellone
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Journal:
Current Drug Targets
Volume:
17
Page:
488-494
Author(s):
Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally
Somatostatin and its Analogs
Journal:
Current Drug Targets
Volume:
17
Page:
529-537
Author(s):
Lichun Sun and David H. Coy
Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization
Journal:
Current Topics in Medicinal Chemistry
Volume:
16
Page:
1427-1440
Author(s):
R.D. Vestal, D.R. LaJeunesse and E.W. Taylor